Skip to content

Clinical trials

Disease Progression trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Clear all

401 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20023
20031
20044
20054
20067
20079
20088
20097
201013
201112
201221
201316
201412
201521
201616
201717
201814
201926
202030
202121
202223
202316
202421
202526
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Unknown status79
Recruiting64
Not yet recruiting30
Active, not recruiting28
Terminated19
Withdrawn14
Enrolling by invitation3
Suspended2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)12
National Cancer Institute (NCI)11
Assistance Publique - Hôpitaux de Paris6
M.D. Anderson Cancer Center5
Mansoura University5
Peking Union Medical College Hospital5
Radboud University Medical Center5
University of Zurich5
Ain Shams University4
AstraZeneca4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression401
Recurrence32
HIV Infections23
Parkinson Disease20
Neoplasms17
Urinary Bladder Neoplasms17
Breast Neoplasms15
Carcinoma, Non-Small-Cell Lung14
Multiple Sclerosis14
Renal Insufficiency, Chronic13

Trials

Showing 76 to 100 of 401. Each trial links to its page on Pharma Observatory.

301 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.